Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Edgen에서 RDY 배당금 데이터를 탐색해 보세요. 포트폴리오 계획을 위한 Dr. Reddy's Laboratories Limited의 배당금 및 주가 추세에 대한 인공지능 기반 통찰력.
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
RDY 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
매출
337,002
75,464
87,534
88,283
85,721
85,284
매출 성장률 (YoY)
3%
-12%
4%
10%
11%
20%
매출원가
122,392
32,127
30,953
31,237
28,075
28,500
매출총이익
214,610
43,337
56,581
57,046
57,646
56,784
판매비와관리비
59,909
14,468
15,885
14,521
15,035
14,006
연구개발 비용
--
--
--
--
--
--
영업비용
167,086
42,449
42,646
41,320
40,671
40,179
기타 비영업 수익(비용)
11,694
2,864
2,688
3,239
2,903
4,817
세전수익(EBT)
53,927
1,997
15,432
17,448
19,050
20,052
법인세비용
12,351
-216
3,536
4,080
4,951
4,185
순이익
41,960
2,209
12,099
13,471
14,181
15,933
순이익 성장률
-26%
-86%
-14%
7%
2%
22%
발행주(희석)
833.58
833.58
833.26
833.08
833.19
834.06
주식 변화 (YoY)
0%
0%
0%
0%
0%
0%
EPS (희석주당이익)
50.33
2.65
14.52
16.17
17.02
19.1
EPS 성장률
-26%
-86%
-14%
7%
2%
22%
잉여현금흐름
18,332
8,412
--
9,920
--
8,552
주당 잉여현금흐름
--
--
--
--
--
--
매출총이익률
63.68%
57.42%
64.63%
64.61%
67.24%
66.58%
영업이익률
14.1%
1.17%
15.91%
17.81%
19.8%
19.47%
이익률
12.45%
2.92%
13.82%
15.25%
16.54%
18.68%
잉여현금흐름마진
5.43%
11.14%
--
11.23%
--
10.02%
EBITDA
68,112
11,669
19,145
25,533
21,736
25,866
EBITDA 마진
20.21%
15.46%
21.87%
28.92%
25.35%
30.32%
D&A for EBITDA
20,588
10,781
5,210
9,807
4,761
9,261
EBIT
47,524
888
13,935
15,726
16,975
16,605
EBIT 마진
14.1%
1.17%
15.91%
17.81%
19.8%
19.47%
실질 세율
22.9%
-10.81%
22.91%
23.38%
25.98%
20.87%
Follow-Up Questions
Quels sont les états financiers clés de Dr. Reddy's Laboratories Limited ?
Selon le dernier état financier (Form-10K), Dr. Reddy's Laboratories Limited a un total d'actifs de $0, un bénéfice net 손실 de $0
Quels sont les ratios financiers clés pour RDY ?
Le ratio de liquidité de Dr. Reddy's Laboratories Limited est 0, la marge nette est 0, les ventes par action sont de $0.
Comment les revenus de Dr. Reddy's Laboratories Limited sont-ils répartis par segment ou géographie ?
Dr. Reddy's Laboratories Limited 주요 수익원은 Global Generics이며, 최신 수익 발표에서 수익은 289,552,000,000입니다. 지역별로는 United States이 Dr. Reddy's Laboratories Limited의 주요 시장이며, 수익은 149,351,000,000입니다.
Dr. Reddy's Laboratories Limited est-elle rentable ?
no, selon les derniers états financiers, Dr. Reddy's Laboratories Limited a un bénéfice net 손실 de $0
Dr. Reddy's Laboratories Limited a-t-elle des passifs ?
no, Dr. Reddy's Laboratories Limited a un passif de 0
Combien d'actions en circulation Dr. Reddy's Laboratories Limited a-t-elle ?
Dr. Reddy's Laboratories Limited a un total d'actions en circulation de 0